15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with Inflammation in 2 studies
15-hydroxy-5,8,11,13,17-eicosapentaenoic acid: structure given in first source; RN given refers to parent cpd
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Excerpt | Relevance | Reference |
---|---|---|
" Here, we found that dietary linseed oil, which contains high amounts of alpha-linolenic acid (ALA) dampened allergic rhinitis through eosinophilic production of 15-hydroxyeicosapentaenoic acid (15-HEPE), a metabolite of eicosapentaenoic acid (EPA)." | 7.91 | Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice. ( Abe, Y; Adachi, J; Aida, K; Arita, M; Fukumitsu, S; Hirata, SI; Hosomi, K; Isoyama, J; Kunisawa, J; Matsunaga, A; Nagatake, T; Sawane, K; Suzuki, H; Tomonaga, T, 2019) |
" Here, we found that dietary linseed oil, which contains high amounts of alpha-linolenic acid (ALA) dampened allergic rhinitis through eosinophilic production of 15-hydroxyeicosapentaenoic acid (15-HEPE), a metabolite of eicosapentaenoic acid (EPA)." | 3.91 | Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice. ( Abe, Y; Adachi, J; Aida, K; Arita, M; Fukumitsu, S; Hirata, SI; Hosomi, K; Isoyama, J; Kunisawa, J; Matsunaga, A; Nagatake, T; Sawane, K; Suzuki, H; Tomonaga, T, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sawane, K | 1 |
Nagatake, T | 1 |
Hosomi, K | 1 |
Hirata, SI | 1 |
Adachi, J | 1 |
Abe, Y | 1 |
Isoyama, J | 1 |
Suzuki, H | 1 |
Matsunaga, A | 1 |
Fukumitsu, S | 1 |
Aida, K | 1 |
Tomonaga, T | 1 |
Arita, M | 1 |
Kunisawa, J | 1 |
Serhan, CN | 1 |
Clish, CB | 1 |
Brannon, J | 1 |
Colgan, SP | 1 |
Chiang, N | 1 |
Gronert, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair.[NCT03208920] | 2 participants (Actual) | Interventional | 2016-12-31 | Completed | |||
Randomised Controlled Trial On The Effects Of Parenteral Fish Oil Emulsion In Patients With Severe Acute Pancreatitis[NCT01745861] | Phase 2 | 44 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and Inflammation